Javid J. Moslehi, MD
NPI 1538123716ActiveIndividual· Internal Medicine, Cardiovascular Disease· San Francisco, CA
Internal Medicine, Cardiovascular Disease (MD) in San Francisco, California, trained at University of Connecticut School of Medicine (class of 2001). 90 Medicare patients in 2024, $19,839 paid; nearly all of their 165 Part D prescriptions were generic (95%). Takeda Pharmaceuticals U.S.A., Inc. was the largest of 8 companies reporting payments in 2025, $27,443 in all, mostly consulting fees.
Overview
| NPI | 1538123716 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Apr 14, 2006 |
| Last updated in NPPES | Jan 24, 2023 |
| Certified by provider | Jan 24, 2023 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Cardiovascular Disease Primary | 207RC0000X | C174811 | CA |
| Internal Medicine | 207R00000X | C174811 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Cardiovascular Disease (Cardiology) (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 90 |
|---|---|
| Services billed | 287 across 12 procedure codes |
| Paid by Medicare | $19,839 |
Part D prescriptions in 2024
| Prescriptions (claims) | 165 · 447 30-day fills |
|---|---|
| Patients | 35 |
| Total drug cost | $22,139 |
| Generic share | 95% of claims |
Education and affiliations
| Medical school | University of Connecticut School of Medicine |
|---|---|
| Graduation year | 2001 |
| Medicare specialty | Cardiovascular Disease (Cardiology) |
| Telehealth | Offers telehealth |
Medical groups
- University of California San FranciscoSan Francisco, CA · 1,839 clinicians
- UCSF Medical Group Business ServicesSan Francisco, CA · 1,598 clinicians
- Regents of the University of CaliforniaSan Francisco, CA · 732 clinicians
Hospital affiliation
- UCSF Medical CenterSan Francisco, CA
Industry payments (Open Payments)
- 2025$27,443 · 15 payments from 8 companies
- 2024$34,647 · 11 payments from 8 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $6,825 | 2 |
| Astrazeneca Pharmaceuticals LP | $6,176 | 2 |
| Sumitomo Pharma America, Inc. | $5,184 | 3 |
| Daiichi Sankyo Inc. | $3,375 | 1 |
| Deciphera Pharmaceuticals Inc. | $3,000 | 2 |
What the 2025 payments were for
- Consulting Fee$24,210 · 13 payments
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$3,150 · 1 payment
- Food and Beverage$83.33 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Cardiovascular Disease providers in San Francisco
- 1306855564
- 1033132048
- 1295747111
- 1366583932
- 1740588102
- 1669611729
- 1922166768
- 1366586950
- 1679665350
- 1316411101
- 1548304157
- 1467783191
All Internal Medicine, Cardiovascular Disease providers in California →